Memorial Sloan Kettering Medical Oncologist Michael Morris

Michael J. Morris, MD

Genitourinary Medical Oncologist

Areas of Expertise

Conditions I Treat

  • Prostate cancer and conditions
  • Metastatic prostate cancer

My Specialties

  • Clinical trials
  • Targeted therapy
  • Combination therapy
View more expertise
Dr. Morris's Office Information
Languages: English
Request an Appointment
Our Care Advisors can answer many of your questions. They will connect you with the best healthcare provider for your needs.

Get to Know Me

I am a board-certified medical oncologist who specializes in treating men with prostate cancer, particularly those with metastatic disease (disease that has spread to distant organs) or those who are at a high risk for developing metastatic disease. I am the Prostate Cancer Section Head, which means I lead a group of experts at Memorial Sloan Kettering Cancer Center (MSK) who are dedicated to researching and treating this disease.

Much of my research focuses on drugs that can deliver radioactive molecules targeted specifically to prostate cancer cells or to the distant areas where the cancer spreads. These drugs can be used alone or in combination with other anti-cancer treatments. This research represents a team effort between medical oncologists, nuclear medicine doctors, and radiologists to bring these novel and exciting drugs to the people with prostate cancer who need them.

This provider is part of a team that was ranked #1 in the nation for Urology Cancer Care this year by U.S. News & World Report.

I am also interested in developing new ways to image prostate cancer using unique, prostate cancer-specific positron emission tomography (PET) scans and other new imaging methods. This type of imaging provides insight into where the prostate cancer is located and also informs us about its biology. We can then use this information to more precisely and personally tailor treatments to a person’s disease.

Additionally, I have an interest in developing new ways to deliver care to people with cancer. To that end, I am one of the principal investigators of MSK’s telehealth research center, MATCHES, which stands for “Making Telehealth Delivery of Cancer Care at Home Effective and Safe.” In August of 2022, the National Cancer Institute (NCI) awarded MSK a grant to create this telehealth research center. Our goal for the center, which is part of the White House’s Cancer Moonshot Program, is to establish best practices for telehealth in cancer care. Through MATCHES, I hope to discover new ways to incorporate telehealth into care delivery patterns for people with cancer and assess how those patterns impact health outcomes and patient satisfaction.

A significant portion of my time is also dedicated to:

  • Reducing barriers that patients face in order to participate in clinical trials
  • Improving the process of drug development

I am a Special Advisor at the NCI. I am also the Co-Director of a new multi-agency unit of the NCI called the Clinical Trials Innovation Unit. This unit brings together the expertise of the NCI, the FDA, and scientists to develop innovative solutions intended to simplify and streamline clinical trials to improve their speed, ease of use, and efficiency. 

What I Do at MSK

I'm a genitourinary (GU) medical oncologist, which is a cancer doctor who specializes in genitourinary (jeh-nih-toh-YOOR-ih-nayr-ee) cancers. This includes bladder, kidney, penis, prostate, and testicular cancers.

  • Prostate Cancer Section Head, Genitourinary Oncology
  • Steven A. Greenberg Chair in Prostate Cancer Research
Areas of Expertise

Conditions I Treat

  • Prostate cancer and conditions
  • Metastatic prostate cancer

My Specialties

  • Clinical trials
  • Targeted therapy
  • Combination therapy
  • Drug development
Education & Honors

Education

  • MD, Mount Sinai School of Medicine

Residencies

  • Medicine - Columbia Presbyterian Medical Center

Fellowships

  • Oncology/Hematology - Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College

Board Certifications

  • Medical Oncology

Awards and Honors

  • Castle Connolly: America’s Top Doctor (2025)
  • Castle Connolly: America’s Top Doctor (2024)
  • Top Doctors New York Metro Area, Castle Connolly (2023)
  • Castle Connolly: America's Top Doctors (2023)
  • Castle Connolly: New York Magazine Top Doctors (2013
  • 2015-2020)

Insurance Information

Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.

Don't see your carrier or plan? We can help you understand your coverage.

If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.

If you have questions about insurance, call us at 646-497-9176.

Make an Appointment

Women talking
New Patients
Scheduling an appointment is easy. Click or call 646-497-9068— we’re available 24 hours a day, 7 days a week
Make an Appointment
Current Patients
Request an appointment by calling your Care Team or messaging them in MSK MyChart.

Contact and Location

Dr. Morris sees patients at one location.

Office Phone
Location
New York, NY
Sidney Kimmel Center for Prostate and Urologic Cancers
353 East 68th Street New York NY 10065
Get Directions

Looking to see a doctor at a different location? See all MSK locations.

Colleagues

Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

See all MATCHES Members doctors

See all Leadership doctors

See all Genitourinary Oncology Service doctors

Clinical Trials

Smiling doctors in the lab
Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Search clinical trials

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Morris’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.

See all on PubMed

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Michael J. Morris discloses the following relationships and financial interests:

  • Ambrx, Inc.
    Professional Services and Activities
  • Amgen Biotecnologica S.A.S.
    Professional Services and Activities (Uncompensated)
  • Arvinas, Inc.
    Professional Services and Activities
  • AstraZeneca
    Professional Services and Activities (Uncompensated)
  • Bayer
    Professional Services and Activities (Uncompensated)
  • Blue Earth Diagnostics
    Professional Services and Activities
  • Bristol-Myers Squibb
    Professional Services and Activities
  • Clarity Pharmaceuticals
    Professional Services and Activities (Uncompensated)
  • Convergent Therapeutics, Inc.
    Professional Services and Activities
  • Daiichi Sankyo
    Professional Services and Activities
  • Doximity, Inc.
    Equity
  • Exelixis
    Professional Services and Activities
  • Flare Therapeutics
    Professional Services and Activities
  • Janssen Research & Development, LLC
    Professional Services and Activities (Uncompensated)
  • Lantheus Medical Imaging, Inc.
    Professional Services and Activities
  • Mashup Media, LLC
    Professional Services and Activities
  • MJH Life Sciences
    Professional Services and Activities
  • Novartis
    Professional Services and Activities (Uncompensated)
  • Prostate Cancer Foundation
    Professional Services and Activities
  • TransThera Sciences (US), Inc.
    Professional Services and Activities
  • Z-Alpha, Inc.
    Professional Services and Activities

If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures

Related topics: